Sign inGet started

OConnell Daniel Joseph

Insider CIK 1865136 · ABOS President and CEO, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ABOS Acumen Pharmaceuticals, In S Sale2026-01-222026-01-232,689$1.88 $5.1K881,275SEC↗
ABOS Acumen Pharmaceuticals, In S Sale2026-01-212026-01-239,346$1.81 $16.9K883,964SEC↗
ABOS Acumen Pharmaceuticals, In A Award deriv2026-01-202026-01-21450,000— $0450,000SEC↗
ABOS Acumen Pharmaceuticals, In A Award2026-01-202026-01-21299,800— $0893,310SEC↗
ABOS Acumen Pharmaceuticals, In S Sale2026-01-122026-01-125,388$1.73 $9.3K593,510SEC↗
ABOS Acumen Pharmaceuticals, In S Sale2026-01-092026-01-1212,941$1.76 $22.8K598,898SEC↗
ABOS Acumen Pharmaceuticals, In S Sale2026-01-082026-01-128,143$1.82 $14.8K611,839SEC↗
ABOS Acumen Pharmaceuticals, In S Sale2026-01-072026-01-0737,755$1.99 $75.1K619,982SEC↗
ABOS Acumen Pharmaceuticals, In S Sale2026-01-062026-01-075,102$1.97 $10.1K657,737SEC↗
ABOS Acumen Pharmaceuticals, In S Sale2026-01-052026-01-074,649$1.97 $9.2K662,839SEC↗
ABOS Acumen Pharmaceuticals, In S Sale2025-01-212025-01-2312,619$1.59 $20.1K667,488SEC↗
ABOS Acumen Pharmaceuticals, In A Award deriv2025-01-072025-01-07338,000— $0338,000SEC↗
ABOS Acumen Pharmaceuticals, In A Award2025-01-072025-01-07225,400— $0680,107SEC↗
ABOS Acumen Pharmaceuticals, In S Sale2025-01-032025-01-0747,778$1.84 $87.9K454,707SEC↗
ABOS Acumen Pharmaceuticals, In S Sale2024-01-192024-01-1915,200$3.47 $52.7K502,485SEC↗
ABOS Acumen Pharmaceuticals, In A Award deriv2024-01-022024-01-04602,000— $0602,000SEC↗
ABOS Acumen Pharmaceuticals, In A Award2024-01-022024-01-04401,000— $0517,685SEC↗
ABOS Acumen Pharmaceuticals, In A Award deriv2023-01-172023-01-18472,500— $0472,500SEC↗
ABOS Acumen Pharmaceuticals, In A Award2023-01-172023-01-18114,000— $0116,685SEC↗
ABOS Acumen Pharmaceuticals, In A Award deriv2022-01-192022-01-21455,000— $0455,000SEC↗
ABOS Acumen Pharmaceuticals, In M Exercise deriv2021-11-302021-12-021,118— $00SEC↗
ABOS Acumen Pharmaceuticals, In M Exercise2021-11-302021-12-021,118$4.47 $5.0K2,685SEC↗
ABOS Acumen Pharmaceuticals, In C Conversion deriv2021-07-062021-07-08123— $00SEC↗
ABOS Acumen Pharmaceuticals, In M Exercise deriv2021-07-062021-07-0835— $00SEC↗
ABOS Acumen Pharmaceuticals, In F Tax w/h2021-07-062021-07-0810$16.00 $1601,567SEC↗
ABOS Acumen Pharmaceuticals, In C Conversion2021-07-062021-07-08123— $01,542SEC↗
ABOS Acumen Pharmaceuticals, In X Exercise2021-07-062021-07-0835$4.47 $1561,577SEC↗